Details for Patent: 10,639,297

Which drugs does patent 10,639,297 protect, and when does it expire?

Patent 10,639,297 protects QLOSI and is included in one NDA.

This patent has twenty-four patent family members in fourteen countries.

Summary for Patent: 10,639,297

Title:	Ophthalmic pharmaceutical compositions and uses relating thereto
Abstract:	The disclosure relates to ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt. Aspects of the disclosure further relate to uses and preparations of ophthalmic pharmaceutical compositions comprising pilocarpine or a pharmaceutically acceptable salt, for correcting presbyopia and other ocular conditions in a subject.
Inventor(s):	Feinbaum Claes, Salamun Franc, Patel Sudhir
Assignee:	Orasis Pharmaceuticals Ltd.
Application Number:	US16032044
Patent Claim Types: see list of patent claims

Drugs Protected by US Patent 10,639,297

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Orasis Pharms	QLOSI	pilocarpine hydrochloride	SOLUTION;OPHTHALMIC	217836-001	Oct 17, 2023		RX	Yes	Yes			Y			TREATMENT OF PRESBYOPIA

International Family Members for US Patent 10,639,297

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2017311636
Australia	2023226732
Brazil	112019002967
Canada	3031370
China	109803652